Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration

Contributed by: Business Wire

Logo

Tags

Science

Biotechnology

Research

Pharmaceutical

Optical

Health

Genetics

Clinical Trials

Series A

More Like This

A Race Against Blindness Announces $2 Million Grant to Support Sight-Saving Clinical Trial

PR Newswire associated0

Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa

A Race Against Blindness Grants $1 Million Supporting Axovia Therapeutics’ Planned Clinical Trial for Bardet-Biedl Syndrome (BBS)

PR Newswire associated0

HUIDAGENE THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN MULTINATIONAL PHASE 1/2 TRIAL OF HG004 FOR INHERITED BLINDNESS

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

PR Newswire associated0

OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product

Robert Dempsey, Chairman of the Board, Azalea Vision

Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform

Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT